Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hanspeter Stalder

10PUBLICATIONS
74CO-AUTHORS
Agricultural molecular engineering of nucleic acids and proteinsCancer cell biologyIndustrial molecular engineering of nucleic acids and proteinsMedical molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Jul 12, 2024
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications.

Jacob Schön, G Tuba Barut, Bettina Salome Trüeb

|Jan 18, 2024
An RNA replicon system to investigate promising inhibitors of feline coronavirus.

Kimberly Schmied, Rosina Ehmann, Claudia Kristen-Burmann

|Oct 07, 2022
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype.

G Tuba Barut, Nico Joel Halwe, Adriano Taddeo

|Feb 26, 2021
SARS-CoV-2 spike D614G change enhances replication and transmission.

Bin Zhou, Tran Thi Nhu Thao, Donata Hoffmann

|Oct 29, 2020
Coronavirus biology and replication: implications for SARS-CoV-2.

Philip V'kovski, Annika Kratzel, Silvio Steiner

|Jul 25, 2020
LY6E impairs coronavirus fusion and confers immune control of viral disease.

Stephanie Pfaender, Katrina B Mar, Eleftherios Michailidis

Pageof 2

Frequent Collaborators

7 joint publications

Volker Thiel

5 joint publications

Jenna N Kelly

5 joint publications

Ronald Dijkman

4 joint publications

Lisa Thomann

3 joint publications

Adriano Taddeo

3 joint publications

Philip V'kovski

3 joint publications

Silvio Steiner

3 joint publications

Donata Hoffmann

3 joint publications

Nico Joel Halwe

3 joint publications

Jörg Jores

Frequent Collaborators

7 joint publications

Volker Thiel

5 joint publications

Jenna N Kelly

5 joint publications

Ronald Dijkman

4 joint publications

Lisa Thomann

Top Related Videos

Efficient Transfection of <em>In vitro</em> Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of <em>In vitro</em> Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on : Aug 17, 2022

3.2K
A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
07:53

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on : Jan 09, 2019

33.2K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.1K
See more related videos

Top Related Videos

Efficient Transfection of <em>In vitro</em> Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of <em>In vitro</em> Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on : Aug 17, 2022

3.2K
A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
07:53

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on : Jan 09, 2019

33.2K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.1K
See more related videos